Özcan, M. Et Al. 2020. A real-world single-center retrospective study on efficacy and safety of pegylated interferon alpha-2a in patients with myeloproliferative neoplasm.. JOURNAL OF CLINICAL ONCOLOGY , vol.38, no.15_suppl , 19536.

Özcan, M., Koyun, D., Cengiz Seval, G., Uslu, A., Kırcalı, E., Ozturk, C., ... Civriz Bozdag, S.(2020). A real-world single-center retrospective study on efficacy and safety of pegylated interferon alpha-2a in patients with myeloproliferative neoplasm.. JOURNAL OF CLINICAL ONCOLOGY , vol.38, no.15_suppl, 19536.

Özcan, MUHİT Et Al. "A real-world single-center retrospective study on efficacy and safety of pegylated interferon alpha-2a in patients with myeloproliferative neoplasm.," JOURNAL OF CLINICAL ONCOLOGY , vol.38, no.15_suppl, 19536, 2020

Özcan, MUHİT Et Al. "A real-world single-center retrospective study on efficacy and safety of pegylated interferon alpha-2a in patients with myeloproliferative neoplasm.." JOURNAL OF CLINICAL ONCOLOGY , vol.38, no.15_suppl, pp.19536, 2020

Özcan, M. Et Al. (2020) . "A real-world single-center retrospective study on efficacy and safety of pegylated interferon alpha-2a in patients with myeloproliferative neoplasm.." JOURNAL OF CLINICAL ONCOLOGY , vol.38, no.15_suppl, p.19536.

@article{article, author={MUHİT ÖZCAN Et Al. }, title={A real-world single-center retrospective study on efficacy and safety of pegylated interferon alpha-2a in patients with myeloproliferative neoplasm.}, journal={JOURNAL OF CLINICAL ONCOLOGY}, year=2020, pages={19536} }